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Vaccinationa b s t r a c t
Infectious diseases are a major threat to the sustainable production of high-producing animals. Control
efforts, such as vaccination or breeding approaches often target improvements to individual resilience
to infections, i.e., they strengthen an animal’s ability to cope with infection, rather than preventing infec-
tion per se. There is increasing evidence for the contribution of non-clinical carriers (animals that become
infected and are infectious but do not develop clinical signs) to the overall health and production of live-
stock populations for a wide range of infectious diseases. Therefore, we strongly advocate a shift of focus
from increasing the disease resilience of individual animals to herd disease resilience as the appropriate
target for sustainable disease control in livestock. Herd disease resilience not only captures the direct
effects of vaccination or host genetics on the health and production performance of individuals but also
the indirect effects on the environmental pathogen load that herd members are exposed to. For diseases
primarily caused by infectious pathogens shed by herd members, these indirect effects on herd resilience
are mediated both by individual susceptibility to infection and by characteristics (magnitude of infec-
tiousness, duration of infectious period) that influence pathogen shedding from infected individuals.
We review what is currently known about how vaccination and selective breeding affect herd disease
resilience and its underlying components, and outline the changes required for improvement. To this pur-
pose, we also seek to clarify and harmonise the terminology used in the different animal science disci-
plines to facilitate future collaborative approaches to infectious disease control in livestock.
Crown Copyright  2021 Published by Elsevier B.V. on behalf of The Animal Consortium. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Implications
Vaccination and breeding programmes that target improve-
ment of herd disease resilience will lead to more effective control
of many infectious diseases in production animals, as they not only
reduce the impact of infectious pathogens on the health and pro-
duction performance of individuals, but also on spread.Introduction
Infectious diseases are one of the most important threats to sus-
tainable livestock production, especially for high-performance ani-
mals that are commonly reared in confined environments that
foster pathogen transmission (Lindström et al., 2012; Craft, 2015).
Climate change, antimicrobial resistance and recent modifications
in agricultural practices and demography have been shown to exac-
erbate pathogen burden (Tomley and Shirley, 2009). Hence, morethan ever, effective disease control is paramount for healthy farming
systems, for national and international food security and for allevi-
ating poverty in developing countries (Tomley and Shirley, 2009).
In addition to biosecurity, vaccination and selective breeding for
increased disease resistance constitute the main preventive mea-
sures against infectious diseases in farmed livestock. However, nei-
ther current vaccines nor the animals’ natural genetic makeup
usually confer full resistance to infection (Meeusen et al., 2007).
Many veterinary vaccines, as well as breeding programmes, miti-
gate the impact of infection on the health and production perfor-
mance of animals by improving their ability to cope with
infection rather than preventing infection per se (Meeusen et al.,
2007; Vale et al., 2016). In other words, they aim to increase the dis-
ease resilience of animals, which has been broadly defined as the
ability of animals to cope with infectious challenge (Bisset and
Morris, 1996) or, for production animals more explicitly as the abil-
ity of animals to maintain high production performance when chal-
lenged by infection (Albers et al., 1987). In a rapidly changing and
increasingly connected world that fosters the circulation of existing
and newly emerging pathogens across regions, countries and conti-
nents, a strong capacity to cope with infections is vital.nimal,
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specific class of animals that appear to cope extremely well with
infections, the so-called non-clinical carriers of infection (Table 1).
These individuals are infected, and presumably infectious, for some
period of time but without any clinical signs suggestive of disease.
In other words, these individuals are both susceptible to infection
and disease resilient. Whilst clearly beneficial for their own health
and well-being, non-clinical carriers can impose a substantial
threat to the health of other animals with whom they come into
contact. The presence of non-clinical individuals has raised major
challenges for the effective control of various infectious diseases
in different species (e.g. Pastoret et al., 1992; Innocent et al.,
1997; Alexandersen et al., 2002; Sánchez-Vizcaíno et al., 2012).
For most diseases, accurate literature estimates for the proportion
of non-clinical carriers of infections in livestock populations are
rare. During the current COVID-19 pandemic, it has been reported
that approximately 40–45% of infected people are asymptomatic
(Oran and Topol, 2020). It is logical to also expect a high proportion
of non-clinical carriers with some livestock infections.
For farmed animals, the role of these disease-resilient individu-
als in the spread and persistence of infections in a population pro-
vokes a potential re-thinking of our current approaches to improve
livestock disease resilience. Important questions to be posed
include: ‘‘How do disease-resilient individuals affect the environ-
mental pathogen landscape?” and ‘‘Is there a risk that improve-
ments in disease resilience, as opposed to resistance to infection,
might inadvertently increase pathogen spread and hence jeopar-
dises disease resilience at the population level, i.e., ‘herd disease
resilience’?”. It is timely to consider the potential impact of current
approaches to improve disease resilience of individual animals,
both with respect to the environmental pathogen load and to
population-level disease severity.
In this paper, we approach the above questions by advocating a
more explicit shift from improved disease resilience of individual
animals to herd disease resilience as the appropriate target for sus-
tainable disease control of livestock. We demonstrate that typically
herd disease resilience is not just the average resilience of its herd
members. In particular, for infections transmitted primarily
through infectious pathogens shed by infected herd members, herd
resilience also contains additional components including the envi-
ronmental pathogen load, individual susceptibility to infection and
the magnitude and duration of infectiousness among those indi-
viduals that do become infected. We introduce various underlying
animal intrinsic component traits of herd disease resilience and
review what is known about how vaccination or selective breeding
affects herd resilience and its underlying components. We propose
future avenues towards more effective vaccination and breeding
programmes for improving herd resilience.
This review also aims to unite concepts and research findings
from diverse research disciplines (e.g. animal production science,
infection and immunity, epidemiology, vaccinology, animal breed-
ing), which often differ in the terminology used. We therefore pro-
vide a glossary of terms used in this perspectives paper (Table 1).Herd resilience instead of individual resilience as a target for
effective disease control
Resilience can be an attribute of an individual animal (individual
resilience), a herd (herd resilience) or an entire production system
(system resilience) (Table 1). In the context of livestock production,
disease resilience has been broadly defined as the ability of an ani-
mal, a herd (a group of animals) or an entire production system
(several herds) to maintain high production performance in the
face of pathogen challenge (after Bisset and Morris, 1996). More
specifically, resilience is the capacity to be minimally affected by2
exposure to infectious pathogens or to rapidly return to the pre-
exposure state (after Colditz and Hine, 2016).
Quantitatively, the disease resilience of a production animal can
be measured in terms of the reduction in health, fitness or produc-
tion performance (reduced from the level expressed in the absence
of infection) when exposed to infectious pathogens (Bisset and
Morris, 1996). In other words, more resilient individuals deviate
less from their health, fitness or performance potential. The magni-
tude of reduction depends on factors relating to the host (e.g. the
individual’s resistance and tolerance, as defined in Table 1), and
on factors relating to the pathogen (e.g. the pathogen’s virulence
and load that the animal is exposed to) (Knap and Doeschl-
Wilson, 2020). Therefore, individual disease resilience is conven-
tionally modelled as the reaction norm of the individual’s health
or performance on environmental pathogen load (Knap and
Doeschl-Wilson, 2020).
Individuals are known to vary genetically in their response to
pathogens, and thus in their disease resilience. Incomplete vaccine
coverage or heterogeneous vaccine response may further exacer-
bate this variation between individual herd members (Raadsma
et al., 1996; 1999; Sanglard et al., 2020).
It is important to note that herd resilience does not usually
equal the average individual resilience of the animals in the herd.
Blanc et al. (2013) made an explicit distinction between herd resi-
lience and individual resilience: ‘‘herd resilience depends on the
adaptive capacity of the animals in the herd (i.e., on individual resi-
lience), together with the management decisions that affect the
performance trajectories and local environment of the animals‘‘.
In the context of diseases that are primarily caused by infectious
pathogens shed by individuals sharing the same environment,
the crucial component of this ”local environment of the animals‘‘
is the pathogen load that individuals are exposed to (hereafter
denoted as environmental pathogen load). Each infected animal
can contribute to the environmental pathogen load, with the
potential to indirectly affect the health and performance of suscep-
tible, in-contact animals. Hence, herd resilience as a whole is more
than the sum of its component parts (the resilience of all individ-
uals in the herd) as it also contains a component that determines
the transmission of infectious pathogens among animals within
the herd. Importantly, when there is variation in individual disease
resilience, strategies that only focus on increasing individual resili-
ence (e.g., by vaccination or genetic selection) may not necessarily
improve the resilience of the herd if they simultaneously increase
the environmental pathogen load, as outlined further below.
Fig. 1 illustrates how individual resilience factors may interact
with epidemiological components relating to environmental
pathogen load, to determine herd resilience for a specific but rela-
tively large range of infectious diseases that can be broadly repre-
sented by compartmental Susceptible-Infectious-Recovered (SIR)
models. There, animals in a herd exposed to infectious pathogens
may transition between three infection states: Susceptible (S),
Infected and Infectious (I), and Recovered (R). The health, fitness
or production performance of infected and recovered animals
may be reduced relative to their performance in the absence of
infection, and this depends partly on their multi-faceted individual
resilience as mentioned above. The epidemiological component of
herd resilience describes how individuals contribute to the envi-
ronmental pathogen load, with potential implications for suscepti-
ble herd members. In the context of the SIR model (Fig. 1), each
individual’s relative contribution to the environmental pathogen
load depends on (i) its susceptibility to infection (which also
directly affects individual resilience), as well as (ii) its infectivity
(i.e., magnitude of infectiousness, Table 1), and (iii) the duration
of its infectious period (i.e., the inverse of its recovery rate in SIR
models if the duration of the infectious period and the duration





Infection Colonisation of an animal’s body tissues and fluids by infectious pathogens
and subsequent multiplication often leading to host innate, humoral and
cellular immune responses (which potentially could result in damage)
Disease caused by
infectious agents
A disorder of structure or function of an infected animal




Propensity to not become infected when exposed to infectious pathogens Conversely, susceptibility to infection is the propensity to
become infected when exposed to infectious pathogens
Resistance to
disease
Propensity to not develop disease when infected Conversely, susceptibility to disease is the propensity to
develop disease when infected
Vaccine efficacy The ability of a vaccine to provide protection against disease under ideal
conditions (e.g. during a clinical trial).
An individual-level measure of vaccine effect, defined as the
reduction in incidence of the target infection/disease in
vaccinated participants compared to controls1
Vaccination
effectiveness
A measure of the extent to which vaccination, when employed under field
conditions, does what it is intended to do for a specified population2
A population measure of vaccine effect, capturing factors
affecting both vaccine efficacy under field conditions and
vaccine coverage (% of the population vaccinated). Often




Average number of secondary cases produced by a typical infectious
individual during its infectious lifetime
If R < 1, the infection will decline and eventually die out.
Super-spreader An infected individual that transmits an infection to an unexpectedly large
number of other individuals
Super-spreaders are known to play an important role in the
epidemiology of many infectious diseases
Animal production and breeding concepts
Recoverability The degree and rate of return to the health and performance state prior to
exposure
Considers both the duration of disease and the potential for
residual effects on health or production performance following
disease recovery
Resilience (generic) Capacity to be minimally affected by disturbances or to rapidly return to the
state pertained before exposure to a disturbance4
Often also referred to as ‘robustness’ which is more commonly
used to describe the combination of a high production




(1) capacity to be minimally affected by exposure to infection or to
rapidly return to the pre-exposure state
(2) ability of animals to maintain high production performance when
challenged by infection 6
Adapted from the generic definition above
Component traits of individual disease resilience These are direct effects, acting on the resilience of the
individual itself
Disease resistance Ability of the individual to inhibit or limit within-host pathogen replication7 This definition encompasses the epidemiological concepts of
resistance to infection. There is inconsistence in the use of this
term in the animal breeding literature, where it has referred to
resistance to infection, to resistance to disease, or to mortality
following exposure
Disease tolerance Ability of an infected host to reduce the impact of infection on performance
and health, i.e. maintain high health or production performance at a given
within-host pathogen load5
Tolerance can only be expressed once an animal has become
infected and therefore expression of tolerance is conditional on
susceptibility to infection. Tolerance encompasses the
epidemiological concept of resistance to disease, as well as
recoverability
Component traits of herd disease resilience
Direct effects, affecting an individual’s own fitness, health and performance
Individual
disease resilience
As defined above The component traits include both resistance and tolerance (as
defined above)
Indirect effects, i.e., additional components relating to environmental pathogen load,
with the potential to affect the health and performance of susceptible herd members
Susceptibility to
infection
As defined above, under epidemiological concepts This is both a direct effect (as it affects the individual’s own
health and performance) and an indirect effect (as only
susceptible individuals can become infected and transmit




Propensity of an infected individual to transmit infection to a typical
(average) susceptible individual
Also referred to as host ‘infectivity’8; typically relates to the
nature and amount of pathogen shedding per unit of time
Duration of
infectious period
The time period over which an animal is infectious Typically related to the duration of pathogen shedding. It is
equal to the inverse of the recovery rate if the duration of the
infectious period and the duration of disease are equal
1 Dean et al. (2019).
2 Porta (2014).
3 Shim and Galvani (2012).
4 Colditz and Hine (2016).
5 Knap and Doeschl-Wilson (2020).
6 Albers et al. (1987).
7 Råberg et al. (2009) and Bishop (2012).
8 Velthuis et al. (2002) and Lipschutz-Powell et al. (2012).
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Fig. 1. A conceptual model of herd disease resilience for diseases primarily caused by infectious pathogens shed by infected herd members. Herd disease resilience
depends on (i) individual disease resilience (represented here by size: larger animals are more resilient, with the contributing mechanism outlined for each individual below)
and on (ii) contribution of infected animals to the environmental pathogen load that susceptible animals in the herd are exposed to (represented here by the number of
pathogen particles). Item (ii) is influenced by factors relating to the pathogen (innate characteristics including transmission potential) and by the host (susceptibility to
infection, magnitude of infectiousness, duration of infectious period). In the context of the epidemiological SIR (Susceptible-Infectious-Recovered) model, where infected
animals are assumed infectious until they reach the recovered state and have long-lasting immunity, these give rise to three epidemiological animal traits relating to
pathogen transmission that influence herd resilience: susceptibility (among susceptible individuals: the probability of infection given exposure), infectivity (or magnitude of
infectiousness; among infected individuals: the nature and amount of pathogen shedding per unit time) and the duration of the infectious period, with levels indicated in the
figure by the animal’s position relative to the corresponding wedges. Susceptible animal A has higher individual resilience than animal B because it is less susceptible to
infection than animal B. As animal A is less likely to become infected given exposure, it is also less likely to contribute to the environmental pathogen load: its expected
positive impact on herd resilience is greater than that of individual B. Infected animal D has a higher individual resilience than infected animal C as it is able to maintain high
production performance (i.e., high tolerance) despite a long infected/infectious period. But animal D contributes more strongly to the environmental pathogen load due to
both a longer infectious period and higher infectivity, therefore, it has a greater negative impact on herd resilience than animal C. Recovered animal E has lower individual
resilience than animal F as it does not fully return to its pre-exposure state. Recovered animals no longer contribute to the environmental pathogen load, hence have no
epidemiological impact on herd resilience. This figure only illustrates the herd resilience components for diseases that can be represented by an epidemiological SIR model.
However, these concepts also apply to a wider range of epidemiological models, including, for example, SEIR (Susceptible-Exposed-Infectious-Recovered) or SIRS
(Susceptible-Infectious-Recovered-Susceptible) models where individuals enter an exposed state before they become infectious or may become susceptible again after they
have recovered.
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resilience but also in those epidemiological traits relating to envi-
ronmental pathogen load (VanDerWaal and Ezwnea, 2016;
Anacleto et al., 2019). Effective disease control that targets herd
resilience could thus target improvement in individual resilience
or any combination of the three above-mentioned epidemiological
animal traits, crucially without negatively impacting the others. For
example, it is not particularly useful to produce highly resilient ani-
mals that can cope with a high pathogen load if such animals also
act as highly infectious super-spreaders that shed large amounts
of pathogens (Gopinath et al., 2014, Beldomenico, 2020). Such indi-
viduals would have detrimental effects on the health and perfor-
mance of less resilient animals in the herd. In contrast,
approaches that reduce the environmental pathogen load (general
biosecurity measures, vaccination, and animal breeding to reduce
individual susceptibility to infection, infectivity and/or duration
of the infectious period) may lead to increased herd disease resili-
ence, evenwhen the average disease resilience of individuals is low.Quantifying herd resilience traits and the impact of
interventions on them
The above-mentioned herd resilience component traits are dif-
ficult to measure directly and thus may need to be estimated from4
available data. Knap and Doeschl-Wilson (2020) provide a review
of current methods for estimating individual disease resilience.
Estimates for the host traits related to pathogen transmission could
be obtained by assessing pathogen shedding from infectious indi-
viduals (e.g., quantity and duration of detectable levels of pathogen
in blood, tissues or faeces or saliva (Pileri and Mateu, 2016;
Tsairidou et al., 2018). However, such measures are not always
available. Also, they may not necessarily correspond to actual
transmission patterns, which also depend on individual contact
behaviour and environmental characteristics (Anderson and May,
1991). Instead, appropriate experimental or field study designs,
coupled with statistical inference methods, may provide more
accurate estimates of individual susceptibility and infectiousness
directly from measurements of individual infection or disease sta-
tus (Longini et al., 1998; Aznar et al., 2011; Pooley et al., 2020).
The transmission of infections, and the impact of interventions,
are often quantified at a population level. The measure used for
this purpose is the reproduction ratio R, which is defined as the
average number of secondary cases produced by a typical infec-
tious individual during its infectious lifetime (Diekmann
et al.,1990). All disease control strategies that aim to reduce trans-
mission aim to reduce R to a threshold value below 1, when infec-
tion will decline and eventually die out. It is commonly known that
individuals can strongly differ in their contribution to R, through
variation in susceptibility and magnitude and duration of infec-
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2016; Anacleto et al., 2019). Estimation of R, and of individual con-
tribution to it and how these are affected by interventions, requires
detailed knowledge about pathogen-specific transmission patterns
and expertise in epidemiological modelling and statistical infer-
ence techniques (see e.g. Diekmann et al., 1990; Lloyd-Smith
et al., 2005).Effects of vaccines on herd resilience
Vaccination is one of the key tools available to control infectious
diseases in livestock. Based on recent estimates, vaccines are avail-
able for over 400 diseases affecting mammals, birds and fish
(Knight-Jones et al., 2014). Within the livestock production sector,
some of the most widely used vaccine applications include those
against Foot-and-Mouth Disease (FMD) in cattle, sheep, goats
and pigs, the Porcine Reproductive and Respiratory Syndrome
(PRRS) in pigs and Marek’s disease in poultry (Knight-Jones and
Rushton, 2013; Tizard, 2021; Witter, 2001). In general, vaccina-
tions improve animal disease resilience by either reducing or elim-
inating the adverse effects that infection causes on health and
survival or productive performance (Knight-Jones et al., 2014).
Whilst most vaccines reduce the probability of disease when
infected (Table 1), surprisingly few livestock vaccines have been
shown to protect animals from either becoming infected or from
transmitting pathogens to other animals.Vaccine efficacy and effectiveness in the context of herd resilience
The degree to which a vaccine boosts the disease resilience of
individuals, the so-called direct effect of vaccination, is routinely
assessed in vaccine efficacy studies, which are compulsory for
licensing a vaccine. The efficacy of a veterinary vaccine is evaluated
as ‘‘the ability of the vaccine to give protection against adverse
effects of the infection to the vaccinated animal” (Pastoret, 1997).
It is typically assessed through challenge studies in which cohorts
of vaccinated and non-vaccinated individuals are infected (usually
through individual inoculation) with the target pathogen under
controlled experimental conditions. The health and performance
status of these two cohorts is subsequently compared.
Vaccination effectiveness refers to the performance of the vac-
cine under real-world conditions (Shim and Galvani, 2012), and
accounts for many factors that may compromise vaccine efficacy
on farm (e.g., timing of vaccination, physiological state of the ani-
mals, variation in animals’ vaccine responsiveness, pathogen strain
variation, etc.) and the vaccination coverage rate (the percentage of
the population receiving and responding to the vaccine, frequency
of vaccination in relation to population and infection dynamics). In
real-world conditions, there is the potential to protect unvacci-
nated individuals through the presence of vaccinated individuals
in a population, through so-called indirect effects of vaccination on
herd members (Shim and Galvani, 2012). In contrast to direct
effects, these indirect vaccine effects are mediated by
intervention-induced changes in pathogen transmission (Halloran
et al., 2010, Bailey et al., 2020). More explicitly, a vaccine is consid-
ered as effective if it can reduce within-host pathogen burden (e.g.,
through increasing host resistance) and pathogen shedding (e.g.,
through reducing host infectivity or the duration of the infectious
period), and prevent or alleviate disease-induced clinical signs
(e.g., through improving host tolerance), thus improving the gen-
eral health conditions of the exposed animals (Meeusen et al.,
2007). Vaccine effectiveness thus targets herd resilience as it con-
siders the direct vaccine effects on individuals’ own resilience as
well as the indirect effect of vaccinated individuals on the perfor-5
mance of others through their contribution to the environmental
pathogen load that others are exposed to (Fig. 1).
To date, there has been limited consideration of the indirect
effects of vaccination for animal health and production. Indeed,
there is only a limited literature that explicitly considers the effect
of vaccines on pathogen transmission. This is in large part because
an assessment of indirect vaccine effects is not required for vaccine
authorization, and because different methodologies are required to
estimate these effects (Longini et al., 1998; Orsel et al., 2007).
Insights from case studies
There is some published information about the epidemiological
effects of vaccination in animal populations which provides valu-
able insights into how vaccines may affect herd resilience. Some
of these insights for different species are considered below.
Bovine tuberculosis in badgers and cattle
Bovine Tuberculosis (bTB, caused by infection with Mycobac-
terium bovis) is a zoonotic disease of bovidae (Banos et al., 2017).
Badger to cattle transmission is one of the reasons contributing
to difficulties faced in seeking to eradicate bTB from the United
Kingdom and Ireland (Allen et al., 2018). The only licensed vaccine
currently available and shown to confer protection againstM. bovis
is the live attenuated Bacille Calmette Guérin (BCG) (Hope and
Villarreal-Ramos, 2008). Application of this vaccine to cattle is
however forbidden under international and EU law because it is
not possible to distinguish, in a diagnostic sense, between vacci-
nated and naturally infected cows. Instead, BCG vaccination of bad-
gers is being used to control M. bovis infection in that wildlife
species (Aznar et al., 2018), with evidence of beneficial down-
stream effects on bTB prevalence in cattle (Martin et al., 2020). A
BCG badger vaccination field trial conducted in Ireland showed
that susceptibility to natural exposure with M. bovis was reduced
in vaccinated compared to placebo treated badgers, with a vaccine
efficacy for susceptibility of 59% (Aznar et al., 2018). However, the
trial revealed a complete lack of vaccine effect on the infectivity of
vaccinated infected badgers, implying that vaccinated badgers
were equally infectious as non-vaccinated badgers when naturally
infected with M. bovis. This lack of indirect vaccination effects on
M. bovis transmission raises demands on vaccination coverage in
badger populations to achieve the desired vaccine effectiveness
for eradicating bTB in badgers and cattle (Aznar et al., 2018).
Foot-and-mouth disease in ruminants and monogastrics and Porcine
Reproductive and Respiratory Syndrome in monogastrics
Foot-and-Mouth Disease, affecting cloven-hooved animals
including cattle, sheep, goats and pigs, and PRRS in pigs, constitute
two economically important livestock diseases for which the
pathological and epidemiological effects of vaccines have been
assessed in several experimental and field studies. Both diseases
are endemic in many countries worldwide, and although mortality
is relatively low, morbidity and infection-induced production
losses are high (Knight-Jones and Rushton, 2013; Nathues et al.,
2017). Further, the presence of these diseases has important trade
implications. Disease control in many areas where FMD or PRRS is
endemic is generally implemented by means of regular mass vac-
cination, which has achieved noticeable success in reducing
disease-associated production losses (Knight-Jones et al., 2014;
Linhares et al., 2015). However, vaccination programmes have also
shown variable and often limited success in reducing infection
prevalence and have raised concerns about the epidemiological
consequences of vaccination and urgent demand for more effective
vaccines (Parida, 2009; Nan et al., 2017). This is particularly the
case for the current modified live vaccines, which have caused sev-
eral safety concerns with regard to the shedding of the modified
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reversion to virulence.
Existing PRRS or FMD vaccines rarely confer sterilizing immu-
nity for heterologous challenge strains, and thus likely only offer
limited protection from infection for the cocktail of circulating
virus strains that pigs are typically exposed to in the field
(Parida, 2009; Nan et al., 2017). Using a comprehensive modelling
framework to assess vaccine effectiveness applied to PRRS,
Bitsouni et al. (2019) demonstrated that vaccines that offer no or
limited protection from infection can still substantially reduce
pathogen transmission and even achieve a value for the reproduc-
tion number, R, below one if vaccine coverage is high and the vac-
cine sufficiently reduces host infectivity or speeds up recovery.
Numerous FMD and PRRS vaccine trials have shown that vacci-
nated animals challenged with a heterologous virus strain usually
have a several fold reduction in shedding of that strain in compar-
ison to unvaccinated control animals, and that virus loads in blood
and other tissues more quickly fall to undetectable levels in vacci-
nated animals (Parida, 2009; Pileri and Mateu, 2016). Transmission
experiments generally confirm that these vaccine effects translate
into reduced FMD or PRRS virus transmission, and thus increased
herd resilience under natural challenge conditions (see e.g., Orsel
et al., 2007; Eblé et al., 2008; van Roermund et al., 2010 for FMD
and Pileri and Mateu, 2016; Chase-Topping et al., 2020 for PRRS).
However, there is considerable variation between these experi-
ments with regard to the nature and actual amount of reduction
in infectious disease transmission, with R values often still remain-
ing considerably greater than one in vaccinated groups. For exam-
ple, Chase-Topping et al. (2020) reported an estimated R value well
above one in vaccinated pigs with the vaccine primarily reducing
the duration of virus shedding of infected pigs. In contrast, in a
study by Rose et al. (2015) R was reduced to a value below one
by the vaccine, simultaneously reducing the duration of shedding
as well as the estimated transmission rate. It would be of benefit
if future vaccine evaluations were to disentangle the vaccine
effects relevant to individual and herd resilience traits, as also indi-
cated in the modelling framework published by Bitsouni et al.
(2019). In particular, closer investigation is needed of the role of
infected individuals without clinical signs (i.e., non-clinical carri-
ers) on the transmission of infection, noting that the prevalence
of non- or subclinical individuals may increase as a consequence
of vaccination (Horter et al., 2002; Paton et al., 2018).
Marek’s disease in poultry
There is increasing awareness that vaccination may not only
affect the host but may also alter the pathogen landscape. Evolu-
tionary theory predicts that leaky vaccines, i.e., those that allow
the host to survive but do not prevent pathogen spread, may drive
pathogen evolution towards increased virulence, thus jeopardising
individual resilience in the long-term (Gandon et al., 2001). This is
particularly pertinent for Marek’s disease (MD) in chicken, where
step jumps in virulence of field strains of MD virus were repeatedly
observed shortly after release of new vaccines (Witter, 1997). As
MD vaccines prevent disease and death but allow viral replication
and transmission, Read et al. (2015) have argued that such leaky
vaccines alter the balance of selection between pathogen transmis-
sion and virulence by allowing more virulent strains to be trans-
mitted at reduced cost. Whilst plausible, direct empirical
evidence from transmission studies that vaccines drive pathogen
evolution to higher virulence is still lacking. Recent transmission
experiments revealed that pathogen transmission from vaccinated
hosts can cause dose-dependent reduction in pathogen virulence
(Bailey et al., 2020). The study showed that non-vaccinated
infected contact birds were less likely to develop disease and shed
significantly less virus when exposed to vaccinated rather than
non-vaccinated infected shedder birds. These results emphasise6
the importance of also considering the indirect effects of vaccina-
tion on non-vaccinated herd members, highlighting the urgent
need for more elaborate transmission experiments and field stud-
ies to fully determine vaccine effects on MD transmission, virus
evolution and herd resilience in the long-term.Infectious diseases in aquaculture
Vaccine use is also becoming more widespread to prevent dis-
ease in aquaculture (Dadar et al., 2017), and has been a key reason
for the success of salmon cultivation (Sommerset et al., 2005). In
aquaculture, vaccine efficacy is mostly assessed through reduction
in mortality rates in vaccinated populations (Dadar et al., 2017).
These often involve so-called bath-challenge experiments, where
vaccinated or naïve fish are exposed to antigens released in water,
which likely mimic natural infection and transmission more clo-
sely than would occur with inoculation methods as used during
efficacy studies in other species.
Very little is known about the impact of vaccines on pathogen
transmission in aquaculture, as in vivo diagnostics of the infection
status rarely exist for these species, and transmission experiments
are extremely rare. Recent reviews report that fish vaccines often
suffer from low efficacy, i.e., they lead to noticeable reduction
but not to zero mortality, indicating that many fish vaccines are
leaky and do not prevent pathogen transmission (Adams, 2019;
Bøgwald and Dalmo, 2019). This was confirmed in a recent trans-
mission trial that assessed vaccination effects on the transmission
of Infectious Salmon Anaemia (ISA) virus in Atlantic salmon, which
showed that ISA vaccination reduced, but did not prevent, patho-
gen transmission and mortality (Chase-Topping et al., 2021). The
study also demonstrates that even small-scale transmission exper-
iments can quantify vaccine effects on the transmission of infec-
tion and herd resilience parameters from mortality records alone
when coupled with epidemiological models, as predicted by simu-
lation studies (Pooley et al., 2020).
In summary, recent studies have demonstrated an indirect vac-
cine effect in some vaccines that were primarily designed to
increase individuals’ resilience to infectious disease. Some vaccines
may add additional benefits, relevant to herd resilience, by reduc-
ing the transmission of infectious pathogens both through
increased resistance to infection and reduced infectiousness. For
most vaccines however, the epidemiological benefits and evolu-
tionary risks are poorly understood. Routine implementation of
transmission experiments, coupled with statistical and epidemio-
logical models in vaccine evaluation studies, would be extremely
useful to determine optimal vaccines that simultaneously boost
individual and herd resilience to infectious diseases. Furthermore,
recent developments in pathogen genome sequencing and phylo-
genetics should provide valuable insights into the effects of vacci-
nation on the pathogen landscape and the corresponding impact
on herd resilience in the long-term (Chong et al., 2010; Hadfield
et al., 2018).Effects of animal breeding on herd resilience
There is overwhelming empirical evidence that animals differ
genetically in their response to infectious pathogens (Bishop,
2010). However, for the majority of prevalent diseases in produc-
tion animals caused by infectious pathogens, and similar to vacci-
nation, the natural genetic make-up rarely offers full protection to
animals from becoming infected. Thus, animals with high genetic
resistance can be susceptible to infection when exposed, can trans-
mit the pathogen, and contribute to the environmental pathogen
load. Hence the epidemiological components introduced in Fig. 1
also likely play an important role for genetic improvement of herd
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by the livestock breeding community.A brief overview of current breeding practices to control infectious
diseases
Genetic disease control, through selective breeding of animals
that genetically respond more robustly to infection, has long been
proposed as a viable alternative or complement to vaccination
(Bisset and Morris, 1996; Stear et al., 2001). Whereas vaccine trials
aim to minimise heterogeneity between animals (Velthuis et al.,
2003), animal breeding relies on and utilises genetic variation to
improve the host response to infection from one generation to
the next. Despite considerable research investment, to date the
livestock breeding sector applies little explicit selection for disease
resilience (see Knap and Doeschl-Wilson, 2020 for a review and
future outlook on this). The primary focus has been on improving
individual disease resistance (see Table 1 under animal production
and breeding concepts), although the exact definition of ‘disease
resistance’ differs in the animal breeding literature across host
and pathogen species, with different implications for herd resili-
ence, as will be outlined below.
Regardless of the exact definition used, breeding for disease
resistance has been implemented in most livestock and aquacul-
ture species (Bishop and Woolliams, 2014; Houston, 2017), albeit
only for a small number of infectious diseases relative to those
tackled with vaccination. Successful examples include the national
sheep breeding programmes for scrapie resistance in several Euro-
pean countries, or marker-assisted selection for infectious pancre-
atic necrosis (IPN) resistance in Atlantic salmon and for E. coli
resistance in pigs. These programmes each resulted in a reduced
infection prevalence to acceptably low levels within less than
10 years of selective breeding (Boelaert et al., 2016; Hjeltnes
et al., 2018; Luther, 2018). However, progress with each of these
diseases can be attributed to the fortuitous but rare discovery ofTable 2
Examples for genetic selection for disease resistance considered in current breeding progr
Disease & Species Resistance phenotype Characteristics of a resistant a
Bovine tuberculosis
(bTB) in cattle
Binary infection status from
in vivo diagnostic skin test
applied in herds exposed to
bTB




Clinical signs (e.g. lameness,
lesions) and mortality after
exposure to MD virus in
challenge trials





Binary survival or time of
death after pathogen exposure
in challenge trials






Parasite egg count in faeces
(Faecal egg counts, FEC)








Blood viral load of pigs over
21 day infection period after
inoculation with the PRRS
virus
Pigs that carry the beneficial
with greater natural8 PRRS re
susceptible to PRRS virus infec
tend to have lower virus repli
1 Banos et al. (2017).
2 Bishop and Woolliams (2014).
3 Bacon et al. (2001).
4 Ødegård et al. (2011).
5 Bisset and Morris (1996).
6 Stear et al. (2001) and Eady et al. (2003).
7 Currently included in genetic evaluations, but not explicitly included in the formal
8 As opposed to resistance through gene editing, which confers full resistance to PRRS
9 Boddicker et al. (2014).
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a single gene with a large effect on disease resistance. For the more
common situation of polygenically controlled disease resistance
(where resistance is primarily controlled by many host genes with
small effects; see for example diseases listed in Table 2), genetic
improvement generally happens at a slower rate, with less obvious
effects on disease prevalence (and thus on herd resilience) in sub-
sequent generations. However, as shown in experimental studies
for gastro-intestinal parasite infections in sheep, genetic selection
for the polygenically controlled faecal egg counts (FEC) can have
a larger and more persistent effect on reducing FEC in the host,
as well as on worm contamination on pasture, than vaccination
or other non-genetic control measures (Eady et al., 2003). Also,
genetic selection for traits that are controlled by many host genes,
such as FEC in the example above, is likely to impose lower risk for
pathogen evolution and thus long-term herd resilience than, for
example., vaccines or genetic selection methods that target few
genes (Woolaston et al., 1992; Kemper et al., 2009).
The long-term effects of breeding for increased resistance (and
for any other trait) are cumulative and permanent. But because the
benefits only occur in subsequent generations, breeding is mostly
considered as a complementary control strategy to vaccination or
other short-term control measures (Bishop and Woolliams, 2014).Impact of selective breeding for disease resistance on herd resilience
In contrast to the vaccine literature, there are very few pub-
lished studies that have quantified the effects of selective breeding
on pathogen transmission from real data (e.g. Eady et al., 2003;
Chase-Topping et al., 2020). Hence, the exact realised impact of
selective breeding for disease resistance on herd resilience is
mostly not known (Fig. 2, left hand panel).
Uncertainty in these effects is exacerbated by the fact that in
the animal breeding literature, the term ‘‘disease resistance” is
not always consistently defined. It often also lacks equivalence to
epidemiological concepts and can refer to different componentsammes, and their potential effect on pathogen transmission and herd resilience.
nimal Effects on pathogen transmission and herd resilience
est result when exposed Some uncertainty in whether genetically more
resistant cows are less likely to become infected and
to transmit bTB2
MD and subsequently Chicken with high genetic resistance can still become
infected and transmit the MD virus1.
Unknown if breeding for MD resistance reduces MD
virus transmission
ed to the pathogen in Unknown whether fish considered genetically more
resistant have greater disease resistance or tolerance,
or both. Unknown if breeding for disease resistance
reduces pathogen transmission.
lity of an animal to limit
h, fecundity and/or
Breeding for disease resistance reduces parasite
shedding and thus the environmental parasite load,
with beneficial effects on herd resilience6
(GBP5) allele associated
sistance are still
tion by inoculation, but
cation9
Currently unknown if pigs that carry the GBP5
resistance allele are more resistant to infection and
less infectious when infected in natural challenge
conditions. Hence the effect of genetic selection on
PRRS virus transmission is unknown.
selection criteria.
virus infection.
Fig. 2. Scheme of a potential future breeding programme with improved herd disease resilience as its breeding objective, contrasted to current approaches focusing
on improved (individual) disease resistance or resilience. Current approaches are in grey (left), proposed future approach is in yellow (right). Innovative components are
highlighted in bold. Abbreviations: SNP = Single Nucleotide Polymorphism; EBV = estimated breeding value.1These herd resilience traits may include individual resilience as
well as host traits controlling pathogen transmission, such as susceptibility to infection, infectivity and duration of the infectious period (see Table 1 and Fig. 1). 2The disease
phenotypes collected may be the same as in the current breeding programmes, or new measures as new diagnostics become available. 3Improved statistical models that
incorporate genetic and epidemiological theory will be used to estimate genetic effects for the diverse herd resilience traits, and their genetic relationship, from observable
disease phenotypes (see section ‘Estimating genetic effects for the epidemiological animal traits’ for further information).4This can be assessed using genetic-epidemiological
simulation models (see section ‘Integrating epidemiological models into quantitative genetics models’ for further information). 5It may not be necessary to explicitly include
all herd resilience traits into the selection index depending on their heritabilities, genetic correlations and prediction accuracies. 6The size of the question mark symbolises
the degree of uncertainty in the outcome of the decision with respect to whether the breeding objective is achieved. We expect this uncertainty to reduce drastically for
breeding programmes that include epidemiological components.
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required to estimate genetic parameters with sufficient accuracy
for breeding purposes, the specific breeding goal trait representing
disease resistance is often determined by the resistance phenotype,
i.e., the trait that can be measured. The diversity of resistance phe-
notypes used may lead to different outcomes for herd resilience.
Table 2 shows some examples of resistance phenotypes considered
in current breeding programmes and anticipated effects on patho-
gen transmission and herd resilience. These illustrate that the suc-
cess of breeding programmes in reducing the transmission of
infectious pathogens depends strongly on the resistance pheno-
type used, and to a large extent is unknown. Consequently, without
explicit consideration of all herd resilience components, in partic-
ular those relating to pathogen transmission, selective breeding for
individual disease resistance as currently practised, is likely sub-
optimal for improving herd resilience.
New approaches enabling selective breeding for improved herd
resilience
Fig. 2 illustrates the changes to a breeding programme required
to shift its breeding objective from improvement of individual dis-
ease resistance (which is often poorly defined) towards improve-
ment of herd resilience for diseases primarily caused by
infectious pathogens shed by infected herd members. This shift
entails two fundamental methodological changes to current8
approaches: (i) the integration of epidemiological models into
the quantitative genetics machinery, and (ii) replacement in the
selection criterion of current individual disease resistance traits
with an index of the herd resilience traits introduced above. The
key benefit arising from these changes is that such a breeding pro-
gramme can improve herd resilience based on predictions of selec-
tion response in the individual animal traits contributing to herd
resilience as well as in disease prevalence at the herd level, which
can be validated with real data.
The proposed changes in breeding programmes will involve
new demands for data recording and computational methods for
estimating genetic and epidemiological effects, as outlined below.
Recent advances in estimating (and genetically improving) individ-
ual disease resilience through their resistance or tolerance have
been described elsewhere (e.g. Knap and Doeschl-Wilson, 2020).
Hence we focus here on the components of herd disease resilience
relating to pathogen transmission.
Integrating epidemiological models into quantitative genetics models
Breeding programmes are underpinned by a strong body of
quantitative genetics theory to estimate genetic and economic
effects associated with the inclusion of specific traits in the selec-
tion criterion (Fig. 2). For example, once genetic parameters (e.g.,
heritability, prediction accuracy) for a particular proxy trait for dis-
ease resistance or resilience (denoted ‘R-trait’ in Fig. 2) have been
estimated, the well-known ‘breeder’s equation’ can be used to
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value over successive generations of selective breeding (Lush,
1937). However, quantitative genetics theory alone cannot predict
how genetic selection for the R-trait affects pathogen transmission.
This is because the relationship between the R-trait and pathogen
transmission is non-linear and depends on the animals’ suscepti-
bility to infection and the infectivity and duration of infectious per-
iod, when infected. Consequently, the impact on pathogen
transmission and therefore on herd resilience of breeding pro-
grammes that build on quantitative genetics theory alone is diffi-
cult to predict (as denoted by the large question mark in the left
hand panel of Fig. 2).
Bishop and Stear (1999) were the first to integrate epidemiolog-
ical theory into quantitative genetics models. Using gastro-
intestinal parasitism in sheep, they demonstrated that the bree-
der’s equation vastly underpredicts the response to selection for
disease resistance in terms of the population’s parasite load when
epidemiological effects are ignored. Various genetic-
epidemiological models have been developed since to predict
how selective breeding reduces the incidence or prevalence of
infectious diseases over successive generations in various animal
species, including fish (e.g., MacKenzie and Bishop, 2001;
Nieuwhof et al., 2009; Gharbi et al., 2015; Raphaka et al., 2018).
However, whilst these models have proven extremely useful for
demonstrating and quantifying the potential epidemiological
effects of selective breeding, they have not been incorporated into
current breeding programmes. This is because these models
require as input genetic parameter estimates for the underlying
animal traits affecting pathogen transmission (e.g., susceptibility
to infection, infectivity, duration of infectious period), which until
recently have been difficult to estimate from existing data.
Estimating genetic effects for herd resilience traits related to pathogen
transmission
Some of the disease resistance phenotypes used to date (see e.g.
Table 2) may be considered as proxies for susceptibility to infec-
tion. In contrast, nematode FEC, the main resistance phenotypes
used in genetic control of gastro-intestinal parasite infections in
sheep (Eady et al., 2003), could be equally considered as a pheno-
type for infectivity as it reflects the amount of parasites shed by an
infected sheep into the environment. However, for the majority of
infectious diseases, genetic parameter estimates for infectivity or
the duration of the infectious period, or for recovery rate as a proxy
of the latter (on the assumption that the duration of the infectious
period and the duration of disease are equal), are extremely scarce.
In particular, despite substantial evidence that individuals vary in
infectivity (e.g. Velthuis et al., 2002), and that highly infectious
super-spreaders are a common phenomenon (Lloyd-Smith et al.,
2005), empirical evidence that infectivity is partly under genetic
control only exists for few infectious diseases (e.g., Albers et al.,
1987; Anacleto et al., 2019). A main reason for this paucity of esti-
mates, and their correlations, is that the herd resilience traits relat-
ing to pathogen transmission can rarely be measured directly (see
section Quantifying herd resilience traits and the impact of interven-
tions on them). Hence genetic parameter estimates for these traits
need to be inferred from data that can be measured, such as the
resistance phenotypes used in current studies (see e.g., those listed
in Table 2). Bishop and Woolliams (2014) outline how the genetic
signal for these resistance phenotypes can be masked by various
sources of noise inherent in these data. Theoretical and empirical
studies indicate that disentangling genetic effects for susceptibility
to infection from those relating to infectivity or recovery either
requires additional data or theoretical expansions of the classical
linear mixed model machinery. For example, in the case of
gastro-intestinal parasite infections, measures related to parasite
establishment or growth in the host, such as worm burden or9
worm length, in addition to the conventional FEC measures, may
help to disentangle host genetic susceptibility from infectivity
(Stear et al., 2001). Recent studies have expanded conventional
quantitative genetics threshold models to enable joint genetic
parameter estimation for susceptibility to, and recovery from, mas-
titis in cattle from routinely collected repeated measures of
somatic cell counts (Franzén et al., 2012; Welderufael et al.,
2016). These studies indicate that susceptibility and recovery are
genetically different traits. Together, these studies indicate that
disease data may comprise considerably more genetic variation
that can be exploited for selective breeding than previously
anticipated.
Estimating genetic effects for infectivity without direct individ-
ual measurements of pathogen shedding proves more difficult,
because an individual’s infectivity affects the infection status of
other individuals, and it is usually not known who infects whom
(Lipschutz-Powell et al., 2012). Several alternative approaches
have been proposed to estimate genetic susceptibility and infectiv-
ity effects (e.g. Anacleto et al., 2015; Biemans et al., 2017; 2019),
and more recently to estimate genetic effects and correlations for
susceptibility to infection, infectivity and recovery rate simultane-
ously (Pooley et al., 2020). All of these incorporate quantitative
genetics methodologies into epidemiological models or vice versa.
Although further developments and validation of these methods is
ongoing, results from both simulated and real data analyses sug-
gest that it is possible to obtain reasonably accurate and unbiased
estimates of genetic effects for these traits from repeated records
of individuals’ infection and/or survival status given appropriate
data structures (e.g., observations from multiple herds or groups
of individuals, in the case of infectivity) (Anacleto et al., 2015;
Biemans et al., 2017; Pooley et al., 2020). This paves the way for
including epidemiological traits and prediction models into a
data-driven breeding programme with improved herd disease resi-
lience as its breeding objective, as shown in Fig. 2. Most livestock
breeding programmes already practise multi-trait selection using
the well-established selection index theory (Lin, 1978). Which of
the above listed herd resilience traits should be included in the
selection index depends largely on their heritabilities and genetic
correlations with each other and with the other traits in the selec-
tion index. It also depends on how accurately the genetic merit for
this trait, and for pathogen transmission can be predicted. The lat-
ter requires epidemiological prediction models.
Emerging empirical insights of the epidemiological effects of selective
breeding
Although still in their infancy, interesting new empirical
insights for herd disease resilience have already started to emerge
from combining genetic and epidemiological methods. For exam-
ple, analysing endemic claw disease digital dermatitis (DD) data
in dairy cattle, Biemans et al. (2019) demonstrated that it is possi-
ble to estimate genomic breeding values for the basic reproduction
number (R0) for this complex disease with reasonable accuracy
from a limited amount of field data, by accounting for genetic vari-
ation in susceptibility and infectivity. IPN virus transmission
experiments in Atlantic salmon revealed that individuals carrying
the beneficial allele for IPN resistance (i.e., conferring lower mor-
tality following exposure) had both lower susceptibility to IPN
virus infection and lower infectivity but also appeared to die
sooner when infected (i.e., had shorter infectious periods)
(Doeschl-Wilson et al., 2018). This extremely fortunate combina-
tion of allelic effects may partly explain the observed success of
existing breeding programmes to drastically reduce IPN outbreaks
within a few years of selection, exceeding expectations based on
quantitative genetics theory (Hjeltnes et al., 2018). However, this
fortunate combination does not always apply. In a similar trans-
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differed in their estimated genomic breeding value for ISA resis-
tance (GEBV, based on mortality records from previous ISA virus
challenge tests) did not differ significantly in their susceptibility
to ISA virus infection (Chase-Topping et al., 2020). However, indi-
viduals with high resistance GEBVs tended to have lower infectiv-
ity and a higher chance to recover or survive the infection,
indicating that selection for ISA resistance improves survival and
reduces transmission of ISA virus infected fish. Interestingly, in this
study the estimated genetic effects on virus transmission were
stronger than the vaccine effects, indicating that vaccination alone
may not always be the most efficient method to improve herd
resilience.Some additional considerations
The concepts and methodologies for herd disease resilience out-
lined in this paper focus on infectious diseases for which individual
animals make an important contribution to the environmental
pathogen load, which then puts other herd members at risk of
infection. Although a wide range of diseases affecting high-
producing farmed animals are primarily caused by infectious
pathogens shed by herd members, this is not always the case.
Examples include situations where infectious pathogens are trans-
mitted primarily by wild hosts (e.g., migratory birds for Avian
Influenza or Newcastle disease, or red deer or feral cattle for
tick-borne diseases in herds where animal to animal transmission
is low, or insects in the case of Akabane virus infections in rumi-
nants or other vector-borne diseases), or diseases caused by patho-
gens that lie dormant in the environment, often for extended
periods (e.g., soil-borne diseases such as Anthrax in cattle and
other herbivores). For these types of diseases, herd disease resili-
ence would be more effectively improved by improving individual
disease resilience and by protecting susceptible animals from
infection through appropriate changes to the animals’ environ-
ment, where possible. Similar arguments may apply to diseases
for which infectious pathogens are not the primary cause. For
example, pink eye or eye cancer in cattle may be caused by com-
mensal organisms that become pathogens due to a change in the
physiological status of the host or due to environmental stressors
(e.g., bright sunlight or high UV exposure) (Walker, 2007;
Lakshmi et al., 2020). Other examples, for which the relative con-
tributions of the epidemiological components to herd resilience
would need to be re-evaluated include reproductive diseases
where the exposure of susceptible individuals to infectious patho-
gens depends to a large extent on management decisions, such as
e.g., those regarding the distribution of semen in artificial breeding
programmes or the use of sires in syndicate mating schemes. In
these cases, low infectivity of the chosen sires may be of even
greater importance for herd resilience.
Perhaps the biggest challenge for increasing herd disease resili-
ence constitute disease complexes that are not caused by a single
aetiological agent, such as the bovine respiratory disease complex
or fleece rot or foot rot in sheep. Transmission patterns may differ
for the different pathogens involved in these complexes, and also
the resilience, susceptibility and infectiousness of individuals
may be pathogen type or strain specific. Consequently, the indirect
effects of vaccination or selective breeding on pathogen transmis-
sion may be particularly difficult to quantify, and hence focusing
on methods that increase individual resilience may be the most
feasible approach in practice.
Similar considerations apply if the goal is to improve herd dis-
ease resilience for multiple types of pathogens at once (i.e., generic
disease resilience), given that farm animals are usually exposed to
multiple types of pathogens at any point in time. Indeed, many10vaccination and genetic studies aim to identify and exploit
immune response mechanisms that offer generic protection to
range of pathogens (e.g., Gunia et al., 2018; Netea et al., 2020;
Ballester et al., 2020). Approaches to estimate individual disease
resilience to multiple pathogens have been proposed (e.g., Putz
et al., 2019). More research into these heterologous genetic and
vaccine effects on various pathogens and their interactions as well
as on pathogen transmission is required to understand their true
impact on herd resilience.
Improving herd disease resilience aims to simultaneously main-
tain high herd-level production performance whilst also reducing
pathogen transmission. However, it may not always be the optimal
or even most appropriate control strategy for infectious diseases. In
particular, if the aim is to eliminate or eradicate a disease, more
drastic interventions with a greater focus on reducing pathogen
transmission, such as movement restrictions and culling of
infected individuals and their potential contacts, may be required.
Improvement of herd disease resilience can complement these and
potentially prevent or reduce the need of such drastic
interventions.Conclusions
Disease control efforts should focus on herd resilience rather
than on individual resilience. For diseases primarily caused by
infectious pathogens shed by herd members, the importance of
improved evaluations of vaccination and breeding programmes
with respect to their influence on pathogen transmission cannot
be overemphasised. Evidence presented above shows that to date
we have limited understanding of the impact of either vaccination
or selective breeding on herd resilience, as the effects on pathogen
transmission are not fully understood. In particular, the results
from empirical and simulation studies suggest that the potential
contribution of selective breeding to reducing the transmission of
infectious pathogens and thus on herd resilience is not yet realised.
Also, very few studies to date have assessed the combined effects
of vaccination and selective breeding on infectious disease preva-
lence and impact, although both methods are frequently applied
jointly. To remedy these shortcomings and design more effective
vaccines or breeding goals for herd disease resilience, a paradigm
shift of our current approaches to control of infectious diseases
in livestock may be required. This shift would include routinely
carried out transmission experiments or field studies coupled with
(genetic-) epidemiological models to capture both the direct
effects of selective breeding or vaccination on individual resilience
to infectious diseases and the indirect effects on herd resilience
mediated through pathogen transmission. In addition, assessment
of vaccination or selective breeding for herd resilience traits on
pathogen evolution is paramount for long-term success of these
strategies. Progress in these areas requires closer collaboration
between the disciplines of infection and immunity, animal breed-
ing and epidemiology, including greater harmonisation in termi-
nologies, as exemplified in this article.Ethics approval
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